Reply

Nov 28, 2016 by in CARDIOLOGY Comments Off on Reply

We would like to thank Andò et al for their interest in our report. We applaud their effort to clarify the optimal threshold dose of contrast agents to prevent contrast-induced acute kidney…

read more

Risk Stratification of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention: Should We Finally Get Rid of Procedural Variables?

Nov 28, 2016 by in CARDIOLOGY Comments Off on Risk Stratification of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention: Should We Finally Get Rid of Procedural Variables?

We read the report by Inohara et al that recently appeared in The American Journal of Cardiology . The investigators developed a preprocedural risk model for contrast-induced acute kidney injury (CI-AKI)…

read more

Reply

Nov 28, 2016 by in CARDIOLOGY Comments Off on Reply

We thank Dr. Kawada for his letter giving us the opportunity to comment further on our results. First, this report should be interpreted in the context of a considerable body…

read more

Reply

Nov 28, 2016 by in CARDIOLOGY Comments Off on Reply

We appreciate the interest in our report, “Overview of the Food and Drug Administration Circulatory System Devices Panel Meetings on WATCHMAN Left Atrial Appendage Closure Therapy” and that it stimulated…

read more

Importance and Feasibility of Creating Hypertrophic Cardiomyopathy Centers in Developing Countries: The Experience in India

Nov 28, 2016 by in CARDIOLOGY Comments Off on Importance and Feasibility of Creating Hypertrophic Cardiomyopathy Centers in Developing Countries: The Experience in India

Hypertrophic cardiomyopathy (HC) is a relatively common genetic heart disease responsible for mortality and morbidity at all ages. Using contemporary treatment advances, such as implantable defibrillators, surgical myectomy, heart transplant,…

read more
Get Clinical Tree app for offline access